Two Sigma Investments, LP Soma Logic, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.76 - $2.83 $476,009 - $765,401	270,460 New	270,460 $684,000
Q1 2023 May 15, 2023	SELL	$2.13 - $3.6 $816,765 - $1.38 Million	-383,458 Reduced 79.66%	97,897 $249,000
Q4 2022 Feb 14, 2023	SELL	$2.05 - $3.47 $215,760 - $365,214	-105,249 Reduced 17.94%	481,355 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $271,244 - $2.36 Million	430,547 Added 275.89%	586,604 $1.7 Million
Q2 2022 Aug 15, 2022	BUY	$4.27 - $8.26 $666,363 - $1.29 Million	156,057 New	156,057 $705,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.